Evidence map›Paper›PMID 27766062›Full record

ArticleThrombosis journal2016

Ming-Ching Shen, Ming Chen, Gwo-Chin Ma, Shun-Ping Chang, Ching-Yeh Lin, Bo-Do Lin, Han-Ni Hsieh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ming-Ching Shen *Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100 Taiwan.
Ming Chen *Department of Genomic Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Gwo-Chin MaDepartment of Genomic Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Shun-Ping ChangDepartment of Genomic Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Ching-Yeh LinDepartment of Internal Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Bo-Do LinDepartment of Internal Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Han-Ni HsiehDepartment of Internal Medicine, Changhua Christian Hospital, Changhua, 500 Taiwan.
Changhua Christian Hospital · TWNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVon Willebrand disease (VWD) is not uncommon in Taiwan. In type 2 or type 3 VWD hemorrhagic symptoms are severer and laboratory data relatively more distinctive.

methodsFifty-four patients belonging to 23 unrelated families from all around the country in whom type 2 VWD exclusive of type 2N has been diagnosed not only by clinical and routine laboratory studies but also by genetic confirmation during 1990-2015 were investigated. A novel technique named amplification refractory mutation system-quantitative polymerase chain reaction (ARMS-qPCR) was used to confirm the presence of somatic mosaicism. Informed consent was obtained for study.

results

conclusion

Indexed as

De novo mutationNovel mutationSomatic mosaicismType 2A VWD

Identifiers

PMID27766062
PMCPMC5056463
OpenAlexW2529285139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.